Handling missing data.
暂无分享,去创建一个
[1] A. Troxel,et al. Statistical analysis of quality of life with missing data in cancer clinical trials. , 1998, Statistics in medicine.
[2] R. McCorkle,et al. Development of a symptom distress scale , 1978, Cancer nursing.
[3] L. Magder,et al. Simple approaches to assess the possible impact of missing outcome information on estimates of risk ratios, odds ratios, and risk differences. , 2003, Controlled clinical trials.
[4] D. Fairclough,et al. Why are missing quality of life data a problem in clinical trials of cancer therapy? , 1998, Statistics in medicine.
[5] J. Sloan,et al. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Vickers,et al. Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one year. , 2003, Controlled clinical trials.
[7] D. Cella,et al. Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing , 1997, Quality of Life Research.
[8] D. Patrick,et al. Assessing meaningful change in quality of life over time: a users' guide for clinicians. , 2002, Mayo Clinic proceedings.
[9] P. Novotny,et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Ian R White,et al. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals , 2004, Clinical trials.
[11] D. Cella,et al. Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. , 1998, Statistics in medicine.
[12] R. Gelber,et al. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data. , 1998, Statistics in Medicine.
[13] J. Sloan,et al. Issues for Statisticians in Conducting Analyses and Translating Results for Quality of Life End Points in Clinical Trials , 2004, Journal of biopharmaceutical statistics.
[14] J. O'fallon,et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Osoba,et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. , 1998, Statistics in medicine.
[16] V. Gebski,et al. Practical approaches to minimize problems with missing quality of life data. , 1998, Statistics in medicine.